These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 4398513)

  • 21. Effect of antilymphocyte serum on the thymus.
    Levey RH; Taub R
    Transplant Proc; 1969 Mar; 1(1):424-8. PubMed ID: 4944253
    [No Abstract]   [Full Text] [Related]  

  • 22. Time-dependence of ALS effects on immunological and haematopoietic activities in mice.
    Nouza K; Haskovcová H; Nĕmec M
    Folia Biol (Praha); 1971; 17(5):312-21. PubMed ID: 4399318
    [No Abstract]   [Full Text] [Related]  

  • 23. Antilymphocyte serum or antithymus serum.
    Nagaya H
    Arch Intern Med; 1970 Mar; 125(3):499-502. PubMed ID: 4906901
    [No Abstract]   [Full Text] [Related]  

  • 24. Experience with large-dose intravenous antithymocyte globulin in primates and man.
    Cosimi AB; Skamene E; Bonney WW; Russell PS
    Surgery; 1970 Jul; 68(1):54-61. PubMed ID: 4193070
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulation and suppression of graft-versus-host reaction.
    Nouza K; Pichlílová
    Allerg Immunol (Leipz); 1973; 19(2-4):279-89. PubMed ID: 4156162
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of the administration of L-asparaginase associated with antilymphocyte serum on skin graft tolerance in mice].
    Maral R; Ganter P; Girard P
    Pathol Biol (Paris); 1973 Apr; 21(4):391-6. PubMed ID: 4576177
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro sensitization to transplantation antigens. I. Sensitization of lymphoid cells by allogeneic macrophages.
    Dyminski JW; Argyris BF
    Transplantation; 1971 Jun; 11(6):514-20. PubMed ID: 4931452
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing.
    Wood ML; Monaco AP; Gozzo JJ; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):676-9. PubMed ID: 4398508
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of antilymphocyte serum: evidence of the maturation process of lymphoid and haemopoietic cells under in vitro cultivation.
    Nouza K; Sejkorova J; Stoyanov SH; Haskovcovà H; Krecek M
    Biomedicine; 1973 Jan; 18(1):38-46. PubMed ID: 4145886
    [No Abstract]   [Full Text] [Related]  

  • 30. Bone marrow transplantation incompatibility modified by F 1 graft inocula.
    Chee CA; Ilbery PL; Motta R
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):53-65. PubMed ID: 4402804
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunochemical assay of antilymphocyte serum with subcellular fractions and purified membranes.
    Von Fellenberg R; Briner HU; Guggisberg E
    J Immunol; 1971 Sep; 107(3):751-6. PubMed ID: 4105933
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of phytohemagglutinin and antilymphocyte serum on the survival time of homologous skin grafts in mice].
    Kaden J; Kaden K
    Z Exp Chir; 1973; 6(6):401-9. PubMed ID: 4152194
    [No Abstract]   [Full Text] [Related]  

  • 33. Antilymphocyte serum and the induction of tolerance to transplantation antigens.
    Lance EM; Medawar PB
    Fed Proc; 1970; 29(1):151-2. PubMed ID: 4391648
    [No Abstract]   [Full Text] [Related]  

  • 34. [The immunepathology of the experimental allo- and xeno-transplantation].
    Grundmann E
    Verh Dtsch Ges Pathol; 1970; 54():65-94. PubMed ID: 4104621
    [No Abstract]   [Full Text] [Related]  

  • 35. [In vitro quantitative determination of the cellular response to skin allografts in mice].
    Degiovanni G
    C R Seances Soc Biol Fil; 1972; 166(4):722-7. PubMed ID: 4568591
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunosuppressive agents].
    Pelletier G
    Laval Med; 1970 Nov; 41(11):1156-60. PubMed ID: 4394730
    [No Abstract]   [Full Text] [Related]  

  • 37. Different sensitivity of H-2K and H-2D incompatibility to ALS immunosuppression.
    Démant P; Nouza K
    Folia Biol (Praha); 1971; 17(6):410-3. PubMed ID: 4400221
    [No Abstract]   [Full Text] [Related]  

  • 38. Allogenic nucleated cells as immunogen and target for plaque-forming cells in mice.
    Fuji H; Zaleski M; Milgrom F
    Transplant Proc; 1971 Mar; 3(1):852-5. PubMed ID: 4398514
    [No Abstract]   [Full Text] [Related]  

  • 39. [Importance of the immunological enhancement for the survival time of a homologous graft].
    Benkö A
    Z Gesamte Inn Med; 1971 Jun; 26(11):345-52. PubMed ID: 4397958
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunosuppression, virus and oncogenesis in mice.
    Nehlsen SL
    Transplant Proc; 1971 Mar; 3(1):811-3. PubMed ID: 4106340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.